Poster: Drug/Disease Modelling - Absorption & PBPK

Development of a PopPK model to predict the oral absorption of Abemaciclib

Thursday 16 October, 2025

Introduction: Abemaciclib is an orally administered drug targeting the cyclin-dependent kinase 4 and 6 (CDK4/6), responsible for tumour growth. It…

Read more

A best practice framework for applying physiologically based pharmacokinetic modelling to predict pH-dependent Drug-Drug Interactions

Thursday 16 October, 2025

Introduction: Predicting drug-drug interactions (DDIs) involving acid-reducing agents (ARAs) is crucial for ensuring drug efficacy and patient safety, as well…

Read more

PBPK Modeling Through Drug-Induced Liver Injury (DILI) Study by Nevirapine and Metabolite Concentrations in Liver Tissue and Blood

Thursday 16 October, 2025

Objectives: Accurate prediction of drug concentrations in liver tissue is essential for understanding drug-induced liver injury (DILI) mechanisms, especially in…

Read more

Prediction of sildenafil concentrations in the central nervous system with physiologically based pharmacokinetic modelling

Thursday 16 October, 2025

Objectives The phosphodiesterase type-5 inhibitor sildenafil is widely used for the treatment of erectile dysfunction and pulmonary hypertension. As it…

Read more

Is flip-flop kinetics a myth?

Thursday 16 October, 2025

Introduction/ Objectives. Flip flop kinetics is being used in pharmacokinetics and pharmacometrics when following oral dosing the absorption half-life is…

Read more

 Development of network-based PBPK models to enhance the confidence in drug-drug interaction predictions

Thursday 16 October, 2025

Introduction: The use of physiologically based pharmacokinetic (PBPK) modeling in regulatory submissions has advanced significantly over time. Among the various applications…

Read more

Physiologically-based pharmacokinetic modeling to support submission of brigimadlin (BI 907828) in dedifferentiated liposarcoma

Thursday 16 October, 2025

Introduction: Brigimadlin is a highly potent, oral MDM2-p53 antagonist [1] for the treatment of cancer patients. After single dose administration,…

Read more

Physiologically based ocular models for protein therapeutics in rabbits and monkeys

Thursday 16 October, 2025

Objectives: Intravitreal (IVT) injection of protein therapeutics is widely used in the treatment of various ocular diseases. Physiologically based ocular…

Read more

Volume of Distribution Covariates That You May not Have Considered!

Thursday 16 October, 2025

Introduction: The volume of distribution (Vd) is a theoretical value defining the relationship between the measured systemic concentration and amount…

Read more

Physiologically-based toxicokinetic modelling of aluminium exposure in humans

Thursday 16 October, 2025

OBJECTIVES: Due to its toxic effects on bone, brain and liver at elevated exposure levels, a detailed understanding of Aluminium…

Read more